Adjustments for Biosimilar Competition Clause Samples

Adjustments for Biosimilar Competition. 7.6.1.1 If the Transfer Price Term extends beyond [ * ] years from the First Commercial Sale in the Territory, and one (1) or more Biosimilar Products are sold in the Territory after [ * ] years from the First Commercial Sale, the Transfer Price to be paid by Teijin to Versartis during the remainder of the Transfer Price Term (the “Remaining Transfer Price Term”) shall be reduced [ * ]; provided, however, that in no case during the Remaining Transfer Price Term shall the Transfer Price be reduced to a rate less than [ * ] percent ([ * ]%) [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.